• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: July 4-8, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

July 4-8, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs7/6/11Annapolis, MDN/AMartin O'Malley (Governer of Maryland)FDA Process
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs7/6/11Silver Spring, MDKaren Midthun, Mary Malarkey, Eric Blumberg, Brenda Holman, Evelyn Bonnin, Richard Davey, Peter LurieShaun Gilmore and several other representatives from American Red CrossAmerican Red Cross
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Caroline Lewis, Acting Deputy Commissioner for Administration7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D.,  Director, Center for Biologics Evaluation and Research7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Meghan Scott, Acting Associate Commissioner for External Affairs7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health7/5/11Silver Spring, MDChristy Foreman, Alberto Gutierrez, William Maisel, Don St. PierreMichael Mahoney, Karen Licitra, Michel Paul, Gary Pruden, Harlan Weisman, Minnie Baylor-Henry (Johnson & Johnson)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health7/6/11Silver Spring, MDJonathan Sackner-Bernstein, William MaiselPeter Regen, Michael Ringel, Peter Lawyer (Boston Consulting Group)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods7/4/11-7/8/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel7/7/11Silver Spring, MDEric Blumberg, Kim Dettelbach, Keith Webber, Elizabeth Dickinson, Martin ShimerKurt Karst, Bob Dormer (Hyman, Phelps & McNamara, P.C.); Dawn Chitty, Kamesh Venugopal (Torrent Pharma Inc.); Alan Minsk (Arnall Golden Gregory LLP)Unapproved ANDA
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs7/5/11Silver Spring, MDThinh Nguyen, John WeinerPaul Brooks and Gerrit Bos (The British Standards Institute)Product Matter
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research7/4/11-7/8/11N/AN/AN/ANo Significant Meetings